Cost-effectiveness of group-based exercise to prevent falls in elderly community-dwelling people.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
26 07 2021
Historique:
received: 30 03 2021
accepted: 06 06 2021
entrez: 27 7 2021
pubmed: 28 7 2021
medline: 10 8 2021
Statut: epublish

Résumé

Clinical studies indicate that strength-balance training for active fall prevention can prevent fractures in older people. The present modelling study evaluates the cost-effectiveness of fall prevention exercise (FPE) provided to independently living older people compared to no intervention in Germany. We designed a Markov model to evaluate the cost-effectiveness of a group-based FPE-program provided to independently living people ≥75 years from the perspective of the German statutory health insurance (SHI). Input data was obtained from public databases, clinical trials and official statistics. The incremental cost-effectiveness ratio (ICER) was presented as costs per avoided hip fracture. Additionally, we performed deterministic and probabilistic sensitivity analyses and, estimated monetary consequences for the SHI in a budget impact analysis (BIA). For women, the costs per hip fracture avoided amounted to €52,864 (men: €169,805). Results of deterministic and probabilistic sensitivity analyses confirmed the robustness of the results. According to the BIA, for the reimbursement of FPE additional costs of €3.0 million (women) and €7.8 million (men) are expected for the SHI. Group-based FPE appears to be no cost-effective option to prevent fall-related hip fractures in independently living elderly. To allow a more comprehensive statement on the cost effectiveness of FPE fracture types other than hip should be increasingly evaluated in clinical trials.

Sections du résumé

BACKGROUND
Clinical studies indicate that strength-balance training for active fall prevention can prevent fractures in older people. The present modelling study evaluates the cost-effectiveness of fall prevention exercise (FPE) provided to independently living older people compared to no intervention in Germany.
METHOD
We designed a Markov model to evaluate the cost-effectiveness of a group-based FPE-program provided to independently living people ≥75 years from the perspective of the German statutory health insurance (SHI). Input data was obtained from public databases, clinical trials and official statistics. The incremental cost-effectiveness ratio (ICER) was presented as costs per avoided hip fracture. Additionally, we performed deterministic and probabilistic sensitivity analyses and, estimated monetary consequences for the SHI in a budget impact analysis (BIA).
RESULTS
For women, the costs per hip fracture avoided amounted to €52,864 (men: €169,805). Results of deterministic and probabilistic sensitivity analyses confirmed the robustness of the results. According to the BIA, for the reimbursement of FPE additional costs of €3.0 million (women) and €7.8 million (men) are expected for the SHI.
CONCLUSIONS
Group-based FPE appears to be no cost-effective option to prevent fall-related hip fractures in independently living elderly. To allow a more comprehensive statement on the cost effectiveness of FPE fracture types other than hip should be increasingly evaluated in clinical trials.

Identifiants

pubmed: 34311698
doi: 10.1186/s12877-021-02329-0
pii: 10.1186/s12877-021-02329-0
pmc: PMC8314607
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

440

Informations de copyright

© 2021. The Author(s).

Références

Injury. 2017 Apr;48(4):819-824
pubmed: 28283181
BMC Musculoskelet Disord. 2017 Jun 5;18(1):243
pubmed: 28583096
Am J Prev Med. 2002 Feb;22(2):120-33
pubmed: 11818183
Acta Orthop. 2009 Oct;80(5):525-30
pubmed: 19916683
Maturitas. 2016 Jul;89:9-15
pubmed: 27180154
J Am Geriatr Soc. 2010 Jan;58(1):136-41
pubmed: 20122044
Br J Sports Med. 2017 Dec;51(24):1750-1758
pubmed: 27707740
Unfallchirurg. 2015 Sep;118(9):780-94
pubmed: 24352202
JAMA. 2019 Jun 4;321(21):2131-2133
pubmed: 31162561
Arch Osteoporos. 2018 Nov 9;13(1):122
pubmed: 30413893
Cochrane Database Syst Rev. 2019 Jan 31;1:CD012424
pubmed: 30703272
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1519-25
pubmed: 26273020
Arch Intern Med. 2010 Sep 27;170(17):1548-56
pubmed: 20876406
J Am Med Dir Assoc. 2015 Jun 1;16(6):490-6
pubmed: 25703448
Gesundheitswesen. 2007 Nov;69(11):601-6
pubmed: 18080931
Int J Environ Res Public Health. 2018 Feb 07;15(2):
pubmed: 29414914
BMC Geriatr. 2015 Mar 26;15:33
pubmed: 25879871
Unfallchirurg. 2008 Sep;111(9):719-26
pubmed: 18584140
Osteoporos Int. 2019 Jul;30(7):1363-1370
pubmed: 30877349
Osteoporos Int. 2014 Oct;25(10):2435-43
pubmed: 25001983
Stroke Vasc Neurol. 2018 Jun 26;3(2):59-68
pubmed: 30191075
Soc Psychiatry Psychiatr Epidemiol. 2018 Aug;53(8):833-839
pubmed: 29721593
Eur J Epidemiol. 2017 Nov;32(11):983-991
pubmed: 28940092
Dtsch Arztebl Int. 2015 Feb 13;112(7):113-9
pubmed: 25780870
Osteoporos Int. 2016 Jan;27(1):193-201
pubmed: 26205890
Value Health. 2008 Jan-Feb;11(1):44-7
pubmed: 18237359
Age Ageing. 2012 Sep;41(5):653-8
pubmed: 22431152
Value Health. 2007 Sep-Oct;10(5):336-47
pubmed: 17888098
Geriatr Orthop Surg Rehabil. 2019 Jan 04;10:2151459318818162
pubmed: 30643663
Inj Prev. 2019 Aug;25(4):258-263
pubmed: 29363590
Health Technol Assess. 2014 Aug;18(49):vii-xxvii, 1-105
pubmed: 25098959
Am J Orthop (Belle Mead NJ). 1999 Jul;28(7):423-8
pubmed: 10426442
Osteoporos Int. 2013 Mar;24(3):835-47
pubmed: 22797490
Appl Health Econ Health Policy. 2017 Oct;15(5):635-645
pubmed: 28349499
Arch Osteoporos. 2013;8:136
pubmed: 24113837
Aust N Z J Public Health. 2012 Jun;36(3):241-8
pubmed: 22672030
BMJ. 2013 Oct 29;347:f6234
pubmed: 24169944
J Am Med Dir Assoc. 2019 Apr;20(4):451-455.e3
pubmed: 30448158
Int J Legal Med. 2018 Nov;132(6):1699-1712
pubmed: 29882059
Pharmacoeconomics. 2008;26(4):311-28
pubmed: 18370566
Int J Prev Med. 2013 Nov;4(11):1282-9
pubmed: 24404363
J Bone Miner Res. 2009 Jul;24(7):1299-307
pubmed: 19257816
J Am Geriatr Soc. 2011 Jan;59(1):148-57
pubmed: 21226685
Am J Orthop (Belle Mead NJ). 1999 Mar;28(3):190-4
pubmed: 10195844

Auteurs

Benjamin Scheckel (B)

Institute of Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Gleueler Str. 176-178, 50935, Cologne, Germany. Benjamin.Scheckel@uk-koeln.de.

Stephanie Stock (S)

Institute of Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Gleueler Str. 176-178, 50935, Cologne, Germany.

Dirk Müller (D)

Institute of Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Gleueler Str. 176-178, 50935, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH